Centers for Disease Control and Prevention. (2021). Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recommendations and Reports, 70(4), 1-187.
[2]
World Health Organization. (2021). Global Health Sector Strategy on Sexually Transmitted Infections 2016-2021. Geneva: WHO Press.
[3]
Brunham, R. C., & Rey-Ladino, J. (2020). Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nature Reviews Immunology, 5(2), 149-161.
[4]
Haggerty, C. L., et al. (2020). Risk of sequelae after Chlamydia trachomatis genital infection in women. Journal of Infectious Diseases, 201(Supplement 2), S134-S145.
[5]
Peters, R. P., et al. (2019). Single-dose azithromycin for the treatment of genital chlamydia infection in women. New England Journal of Medicine, 381(18), 1723-1733.
[6]
Workowski, K. A., & Bolan, G. A. (2021). Sexually transmitted diseases treatment guidelines. Clinical Infectious Diseases, 72(Supplement 1), S1-S19.
[7]
Price, M. J., et al. (2020). Cost-effectiveness of screening for Chlamydia trachomatis in women. Sexually Transmitted Infections, 96(3), 178-184.
[8]
Kreisel, K. M., et al. (2021). Sexually transmitted infections among US women and men. Sexually Transmitted Diseases, 48(2), 87-93.